Dibromodifluoromethane → 4-[5-(2,2-Difluoro-vinyl)-thiazol-2-yl]-piperazine-1-carboxylic acid tert-butyl ester

HRID 1352371

Reaktionsgleichung

Reaktionsgleichung von HRID 1352371
C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.Br[C:21](Br)([F:23])[F:22].[C:25]([O:29][C:30]([N:32]1[CH2:37][CH2:36][N:35]([C:38]2[S:39][C:40]([CH:43]=O)=[CH:41][N:42]=2)[CH2:34][CH2:33]1)=[O:31])([CH3:28])([CH3:27])[CH3:26]>CN(C)C=O.[Zn]>[C:25]([O:29][C:30]([N:32]1[CH2:37][CH2:36][N:35]([C:38]2[S:39][C:40]([CH:43]=[C:21]([F:23])[F:22])=[CH:41][N:42]=2)[CH2:34][CH2:33]1)=[O:31])([CH3:28])([CH3:27])[CH3:26]

Komponenten

6

Versuchsvorschrift

To a solution of 6.73 mmol triphenylphosphine in 13 ml N,N-dimethylformamide was added 6.73 mmol dibromodifluoromethane and the mixture was stirred at room temperature for 1 h. 3.36 mmol 4-(5-formyl-thiazol-2-yl)-piperazine-1-carboxylic acid tert-butyl ester was added and the mixture was then cooled to 0° C. 6.73 mmol zinc dust was added in small portions and stirring continued for 10 min at 0° C. The mixture was then allowed to warm to room temperature and stirring continued for a further 2 h. The reaction mixture was then filtered and the filtrate was concentrated in vacuo. The residue was purified by chromatography (SiO2, ethyl acetate/heptane) to afford the title compound as a white crystalline solid (yield 19%). MS (m/e): 332.3 (M+H+, 10%), 276.0 ([M+2H−tBu]+, 100%).

Aufarbeitung

  1. temperaturethe mixture was then cooled to 0° C
  2. stirringstirring
  3. waitcontinued for 10 min at 0° C
  4. temperatureto warm to room temperature
  5. stirringstirring
  6. waitcontinued for a further 2 h
  7. filtrationThe reaction mixture was then filtered
  8. concentrationthe filtrate was concentrated in vacuo
  9. customThe residue was purified by chromatography (SiO2, ethyl acetate/heptane)

Quellen und Nachweise

ORD-Eintrag
ord-893b7398074045f48b844b52356d1857
Quelldatensatz
uspto-grants-2007_05
Patentnummer
US07220744B2

Verknüpfte Notizen

Wird geladen…